Quarterly Result18 Nov 2025, 05:41 pm
Wanbury Ltd Delivers Robust H1 FY26 Performance with 216.6% YoY Jump in PAT
AI Summary
Wanbury Ltd, a pharmaceutical company, has announced its financial results for the quarter and half year ended 30 September, 2025. The company reported a significant increase in profit after tax (PAT) by 216.6% YoY to Rs.28.7 Cr, driven by volume growth, cost efficiencies, improved product yield, and lower finance cost. The revenue from operations for H1 FY26 stood at Rs. 323.2 crore, up by 10.6% YoY. The EBITDA for H1 FY26 stood at Rs.50.8 crore, registering a growth of 51.3%.
Key Highlights
- PAT jumps 216.6% YoY to Rs.28.7 Cr
- Revenue from operations for H1 FY26 stood at Rs. 323.2 crore, up by 10.6% YoY
- EBITDA for H1 FY26 stood at Rs.50.8 crore, registering a growth of 51.3%
- Improved product yield and lower finance cost drove the growth
- Wanbury's Formulations business turned EBITDA positive